2 weeks Ago By Defense World Staff
Dimensional Fund Advisors LP raised its stake in Align Technology, Inc. ( NASDAQ:ALGN – Free Report ) by 13.7% during the second quarter, according to its most recent disclosure with the SEC.
The fund owned 264,524 shares of the medical equipment provider’s stock after buying an additional 31,948 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.35% of Align Technology worth $63,873,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Achmea Investment Management B.V.
increased its stake in Align Technology by 3.4% during the 2nd quarter. Achmea Investment Management B.
V. now owns 10,335 shares of the medical equipment provider’s stock valued at $2,495,000 after buying an additional 339 shares during the period. Tidal Investments LLC grew its position in Align Technology by 122.
9% during the first quarter. Tidal Investments LLC now owns 4,408 shares of the medical equipment provider’s stock valued at $1,445,000 after purchasing an additional 2,430 shares in the last quarter. Nomura Holdings Inc.
acquired a new stake in Align Technology during the fourth quarter valued at $1,197,000. Norden Group LLC raised its position in Align Technology by 3,647.7% during the first quarter.
Norden Group LLC now owns 36,540 shares of the medical equipment provider’s stock valued at $11,982,000 after acquiring an additional 35,565 shares in the last quarter. Finally, Bares Capital Management Inc. boosted its holdings in Align Technology by 22.
6% in the fourth quarter. Bares Capital Management Inc. now owns 567,710 shares of the medical equipment provider’s stock worth $155,553,000 after purchasing an additional 104,799 shares in the last quarter.
Institutional investors own 88.43% of the company’s stock. Insider Buying and Selling at Align Technology In other Align Technology news, Director C Raymond Larkin, Jr.
acquired 6,500 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was acquired at an average price of $235.33 per share, for a total transaction of $1,529,645.
00. Following the purchase, the director now directly owns 28,247 shares of the company’s stock, valued at $6,647,366.51.
The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink . Corporate insiders own 0.62% of the company’s stock.
Wall Street Analysts Forecast Growth Get Our Latest Research Report on Align Technology Align Technology Trading Up 2.1 % ALGN stock opened at $254.81 on Friday.
Align Technology, Inc. has a 1-year low of $176.34 and a 1-year high of $335.
40. The firm has a market cap of $19.03 billion, a PE ratio of 41.
98, a P/E/G ratio of 5.77 and a beta of 1.64.
The business’s 50-day moving average price is $232.61 and its two-hundred day moving average price is $263.24.
Align Technology ( NASDAQ:ALGN – Get Free Report ) last issued its quarterly earnings results on Wednesday, July 24th. The medical equipment provider reported $2.41 EPS for the quarter, beating the consensus estimate of $2.
32 by $0.09. The firm had revenue of $1.
03 billion during the quarter, compared to analysts’ expectations of $1.04 billion. Align Technology had a return on equity of 14.
07% and a net margin of 11.34%. The business’s quarterly revenue was up 2.
6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.73 earnings per share.
On average, analysts forecast that Align Technology, Inc. will post 7.61 earnings per share for the current year.
About Align Technology ( Free Report ) Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. Featured Articles Five stocks we like better than Align Technology Using the MarketBeat Dividend Yield Calculator Can Costco Stock Hit New Highs as Interest Rates Drop? How to Invest in the Best Canadian Stocks These 3 Stocks Show How to Navigate Declining Consumer Confidence Investing In Automotive Stocks MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy? Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Align Technology, Inc. ( NASDAQ:ALGN – Free Report ). Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.
com's FREE daily email newsletter ..
